XML 19 R6.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Balance at Dec. 31, 2022   $ 1 $ 422,981 $ (1,316) $ (405,727) $ 15,939
Balance (in shares) at Dec. 31, 2022 573,282 628,139        
Stock-based compensation     401     401
Preferred stock dividends     (50)     (50)
Unrealized foreign exchange on intercompany loans       5,263   5,263
Translation adjustment       (5,171)   (5,171)
Loss for the period         (5,804) (5,804)
Balance at Mar. 31, 2023   $ 1 423,332 (1,224) (411,531) 10,578
Balance (in shares) at Mar. 31, 2023 573,282 628,139        
Balance at Dec. 31, 2023   $ 1 429,796 (908) (428,282) 607
Balance (in shares) at Dec. 31, 2023 454,537 1,058,892        
Issue of common stock upon conversion of pre-funded warrants in underwritten offering net of issuance costs     (80)     (80)
Issue of common stock upon conversion of pre-funded warrants in underwritten offering net of issuance costs (in share)   219,700        
Series B Preferred stock conversions (in shares) (119,000) 39,667        
Stock-based compensation     203     203
Unrealized foreign exchange on intercompany loans       (2,130)   (2,130)
Translation adjustment       2,140   2,140
Loss for the period         (2,946) (2,946)
Balance at Mar. 31, 2024   $ 1 $ 429,919 $ (898) $ (431,228) $ (2,206)
Balance (in shares) at Mar. 31, 2024 335,537 1,318,259